Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
Year: 2017
Type: article
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1701990
Institution: Brigham and Women's Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2624032915